Project Grant 2008PMBX0008

This $1.4 million cooperative agreement from the Department of Justice Office of Justice Programs Bureau of Justice Assistance will support implementation of Missouri's first statewide prescription drug monitoring program under the Harold Rogers Prescription Drug Monitoring Program. The Joint Oversight Task Force for Prescription Drug Monitoring will utilize funding to train and educate prescribers and dispensers throughout the state on processes to submit data and comply with Missouri law. This...

The National Institute on Drug Abuse awarded the University of Alabama at Birmingham $409,750 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a secondary data analysis of national Medicaid claims examining variations in clinician responses to Prescription Drug Monitoring Program mandates. The recipient will analyze how emergency department, urgent care, and primary care clinicians adopt opioid prescribing regulations and policies differently,...

The Department of Health and Human Services Agency for Healthcare Research and Quality awarded Oregon State University a $740,620 Project Grant under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) to evaluate the integration of state prescription drug monitoring programs into electronic health records. Oregon Health & Science University and Comagine Health were named as sub-awardees to provide integration services for OHSU's Epic EHR system and support...

The Supreme Court of Ohio received a $962,064.75 cooperative agreement award from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program. The award period is from October 1, 2017 through July 31, 2022 to enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through the state's centralized prescription drug monitoring database, as outlined...

The National Institute on Drug Abuse awarded the University of Pittsburgh $945,601 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 30, 2025, for the Personalized Methadone Treatment (PROMOTE) study implementing shared decision making in opioid treatment programs. The project adapts implementation facilitation—a bundle of preparation, implementation, and sustainment strategies—to support systematic shared decision making (SDM) implementation within opioid treatment...

The San Francisco Department of Public Health (SFDPH) was awarded a $1,600,000 Project Grant by the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant will fund the implementation of the "Data-Driven Health Systems Change for Prevention" (DHSCP) program, which aims to develop a comprehensive, collaborative, and innovative Overdose Fatality Review (OFR) process in San Francisco. Key expected outcomes...

The National Institute on Drug Abuse awarded Boston Medical Center Corporation $2.67 million on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and implement LINK, a system-wide informatics intervention designed to optimize medications for opioid use disorder (MOUD) and pre-exposure prophylaxis for HIV (PrEP) utilization and reduce missed opportunities to prevent opioid overdose and HIV infection. LINK comprises two integrated components: LINK2CARE, a...

The National Institute on Drug Abuse awarded Labsys LLC $302,225 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a wearable Continuous Polydrug Monitor (CPM) for substance use disorder treatment. The CPM is a wearable electrochemical sensor that continuously tracks fentanyl and other high-risk substances in interstitial fluid, using computationally designed anchor molecules for drug recognition, conductive polymers for signal amplification, and...

The National Institute on Drug Abuse awarded The Johns Hopkins University $155,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 1, 2026, to develop and pilot the PROTECT-ED intervention, which addresses overdose and HIV prevention for individuals recently released from incarceration. The award funds research to refine and test an emergency department–based intervention designed to identify recently incarcerated patients and offer same-day medications for opioid...

This $765,628 Project Grant awarded by the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and Substance Use Program (CFDA 16.838) supports a collaborative initiative led by the Jefferson County Health Department in Missouri. The key products and services to be delivered through this 3-year grant, which began on October 1, 2024, include: Enhancing drug take-back programs in Jefferson County to increase the capacity for receiving and safely disposing of...